Healthcare Value Capital as of Sept. 30, 2014
Portfolio Holdings for Healthcare Value Capital
Healthcare Value Capital holds 27 positions in its portfolio as reported in the September 2014 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Actavis | 12.8 | $13M | 55k | 241.28 | |
| Ultra Short Russell 2000 | 10.7 | $11M | 225k | 49.22 | |
| Albany Molecular Research | 10.6 | $11M | 498k | 22.07 | |
| Biosante Pharmaceuticals (ANIP) | 9.6 | $9.9M | 350k | 28.28 | |
| AstraZeneca (AZN) | 8.6 | $8.9M | 125k | 71.44 | |
| Pfizer (PFE) | 8.6 | $8.9M | 300k | 29.57 | |
| Auxilium Pharmaceuticals | 5.8 | $6.0M | 200k | 29.85 | |
| Merck & Co (MRK) | 5.7 | $5.9M | 100k | 59.28 | |
| Teva Pharmaceutical Industries (TEVA) | 5.2 | $5.4M | 100k | 53.75 | |
| Quest Diagnostics Incorporated (DGX) | 4.5 | $4.7M | 77k | 60.68 | |
| Ipath S&p 500 Vix S/t Fu Etn | 3.0 | $3.1M | 100k | 31.18 | |
| Bristol Myers Squibb (BMY) | 2.5 | $2.6M | 50k | 51.18 | |
| Proshares Tr ultsh nasd biot | 2.3 | $2.4M | 200k | 12.04 | |
| Ligand Pharmaceuticals In (LGND) | 2.3 | $2.4M | 50k | 47.00 | |
| Clovis Oncology | 1.1 | $1.1M | 25k | 45.36 | |
| Sorrento Therapeutics (SRNEQ) | 1.1 | $1.1M | 241k | 4.52 | |
| Ariad Pharmaceuticals | 1.0 | $1.1M | 200k | 5.40 | |
| Sunesis Pharmaceuticals | 0.9 | $895k | 125k | 7.16 | |
| Rigel Pharmaceuticals (RIGL) | 0.8 | $776k | 400k | 1.94 | |
| CryoLife (AORT) | 0.7 | $740k | 75k | 9.87 | |
| Cempra | 0.5 | $548k | 50k | 10.96 | |
| Kindred Biosciences | 0.5 | $463k | 50k | 9.26 | |
| Fibrocell Science | 0.4 | $458k | 158k | 2.90 | |
| Sucampo Pharmaceuticals | 0.3 | $336k | 52k | 6.51 | |
| Celsion Corporation | 0.3 | $296k | 100k | 2.96 | |
| D Stemline Therapeutics | 0.2 | $205k | 17k | 12.45 | |
| Zogenix | 0.2 | $173k | 150k | 1.15 |
